AbbVie : ABBV

All AbbVie Articles

587 Articles

Lee Jackson | Feb 3, 2017 at 8:25 AM EST

Jefferies Adds Big Dividend-Paying Leader to Franchise Picks List

Jefferies has made a third big change for 2017 by adding Marathon Petroleum to the Franchise Picks list. Plus, three…

Chris Lange | Jan 27, 2017 at 8:45 AM EST

AbbVie Slides on Mixed Q4 Earnings

AbbVie reported mixed fourth-quarter financial results and offered guidance before the markets opened on Friday.

Chris Lange | Jan 26, 2017 at 9:50 AM EST

Short Sellers Run for Cover From Major Pharma

The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 25, 2017 at 11:25 AM EST

What to Expect From Major Health Care Stocks Reporting This Week

The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already…

Lee Jackson | Jan 23, 2017 at 9:55 AM EST

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks…

Chris Lange | Jan 22, 2017 at 10:40 AM EST

7 Key Earnings Coming This Week

24/7 Wall St. has put together a preview of AT&T, AbbVie, Starbucks and some of the major companies scheduled to…

Chris Lange | Jan 12, 2017 at 10:50 AM EST

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a…

Chris Lange | Dec 28, 2016 at 10:25 AM EST

Short Interest Rises in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest increased in most of…

Lee Jackson | Dec 27, 2016 at 10:25 AM EST

Jefferies Makes Huge Year-End Addition to Franchise Picks List

A top new addition to the Franchise list portfolio and three additional dividend stocks that the Jefferies team views as…

Chris Lange | Dec 12, 2016 at 8:44 AM EST

Short Sellers Back Way Off Major Pharma Stocks

The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected…

Lee Jackson | Dec 5, 2016 at 10:05 AM EST

Bond Sell-Off Could Be Huge for Stocks: 4 Analyst Top Pick Dividend Stocks to Buy Now

With money expected to come out of the bond market, these four stocks are an attractive alternative that have solid…

Chris Lange | Nov 28, 2016 at 7:15 AM EST

Short Sellers Hike Their Bets in Most Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the…

Lee Jackson | Nov 22, 2016 at 9:40 AM EST

Jefferies Makes Another Huge Addition to Franchise Picks Stocks Portfolio

[cnxvideo id=”506829″ placement=”ros”] With earnings for the third quarter over, and the fourth quarter of 2016 in full swing, many…

Chris Lange | Nov 10, 2016 at 7:40 AM EST

Short Interest Bets Increase on Major Pharma

Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these…

Lee Jackson | Nov 7, 2016 at 10:05 AM EST

Jefferies Makes a Huge Q4 Change to the Franchise Picks List

In a recent research note, the analysts at Jefferies make a big move by removing a top medical devices company…

1 … 25 26 27 28 29 … 40

AbbVie : ABBV

All AbbVie Articles

Jefferies Adds Big Dividend-Paying Leader to Franchise Picks List

AbbVie Slides on Mixed Q4 Earnings

Short Sellers Run for Cover From Major Pharma

What to Expect From Major Health Care Stocks Reporting This Week

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

7 Key Earnings Coming This Week

Major Pharma Short Interest Declines Ahead of Trump Comments

Short Interest Rises in Major Pharma

Jefferies Makes Huge Year-End Addition to Franchise Picks List

Short Sellers Back Way Off Major Pharma Stocks

Bond Sell-Off Could Be Huge for Stocks: 4 Analyst Top Pick Dividend Stocks to Buy Now

Short Sellers Hike Their Bets in Most Major Pharma Stocks

Jefferies Makes Another Huge Addition to Franchise Picks Stocks Portfolio

Short Interest Bets Increase on Major Pharma

Jefferies Makes a Huge Q4 Change to the Franchise Picks List

A Covered Call ETF That Pays 6% Is Beating Vanguard’s Biggest International ETF Right Now

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

A $2.5 Million 401(k) at 73 Can Still Cost You Six Figures Without These 3 Moves

A Covered Call ETF That Pays 6% Is Beating Vanguard’s Biggest International ETF Right Now

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

AbbVie : ABBV

All AbbVie Articles

Jefferies Adds Big Dividend-Paying Leader to Franchise Picks List

AbbVie Slides on Mixed Q4 Earnings

Short Sellers Run for Cover From Major Pharma

What to Expect From Major Health Care Stocks Reporting This Week

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

7 Key Earnings Coming This Week

Major Pharma Short Interest Declines Ahead of Trump Comments

Short Interest Rises in Major Pharma

Jefferies Makes Huge Year-End Addition to Franchise Picks List

Short Sellers Back Way Off Major Pharma Stocks

Bond Sell-Off Could Be Huge for Stocks: 4 Analyst Top Pick Dividend Stocks to Buy Now

Short Sellers Hike Their Bets in Most Major Pharma Stocks

Jefferies Makes Another Huge Addition to Franchise Picks Stocks Portfolio

Short Interest Bets Increase on Major Pharma

Jefferies Makes a Huge Q4 Change to the Franchise Picks List

A Covered Call ETF That Pays 6% Is Beating Vanguard’s Biggest International ETF Right Now

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

Featured Reads

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

A $2.5 Million 401(k) at 73 Can Still Cost You Six Figures Without These 3 Moves